Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Novobiocin Sodium: From Gyrase to Translation
2026-08-25
Novobiocin Sodium is more than a classic DNA gyrase probe: it is a translational research tool for connecting replication stress, cellular selectivity, and antiparasitic discovery. This article interprets recent in vitro evidence against Toxoplasma gondii, outlines disciplined experimental workflows, and defines the opportunities and limitations that separate mechanistic insight from therapeutic promise.
-
Nuclear-Targeted Nanorods Activate STING with DMXAA
2026-08-24
The 2024 Journal of Controlled Release study developed PFPD, a chimeric peptide nanorod that combines nuclear photodynamic DNA damage with DMXAA-mediated STING activation. This sequential delivery strategy enhanced innate and adaptive antitumor immunity and suppressed lung metastatic tumors in preclinical models.
-
mCherry mRNA Workflow for Reliable Cell Assays
2026-08-24
Build a reproducible fluorescent reporter workflow with Cap 1, 5mCTP, ψUTP, and an optimized poly(A) tail. Use this red fluorescent protein mRNA to compare transfection or lipid nanoparticle delivery before committing valuable gene-editing payloads.
-
Fenipentol: From Chuanxiong Chemistry to Translation
2026-08-23
Fenipentol, also known as 1-Phenyl-1-pentanol, offers a distinctive translational bridge between volatile natural-product chemistry, estrogen receptor α biology, and gastrointestinal secretion research. This article outlines how researchers can move from docking and metabolomics signals toward rigorous functional validation without overstating clinical relevance.
-
Puerarin, Gut Microbiota, and Adipose Thermogenesis
2026-08-22
A 2026 Phytotherapy Research study links puerarin’s metabolic benefits in diabetic mice to coordinated changes in gut microbiota, fecal butyrate, GLP-1 secretion, and adipose thermogenesis. Its multi-omics and pathway analyses provide a useful mechanistic framework, while the mouse model and largely associative microbiota evidence limit immediate clinical translation.
-
Trilaurin (Glycerol Tridodecanoate): Lab Guide
2026-08-22
Trilaurin (BA7536) provides a water-insoluble, long-chain triacylglycerol C12 for lipid formulation and enzymatic substrate workflows. This guide explains solvent selection, handling, QC, and application boundaries; it is not intended for aqueous-only work or as evidence of clinical or therapeutic performance.
-
Flubendazole for Autophagy Research Workflows
2026-08-21
Flubendazole provides a DMSO-soluble route to perturb autophagy while researchers examine metabolic remodeling in hepatic stellate cells, cancer models, and other systems. This guide translates a liver-fibrosis study into practical assay design, with stock-preparation guidance, flux-focused readouts, and troubleshooting strategies.
-
Separating Growth Inhibition from Cancer Cell Death
2026-08-20
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly interchangeable readouts capture different components of drug response. The work argues for measuring proliferation arrest and cell killing separately, with attention to their proportions and timing, to improve interpretation of in vitro cancer drug assays.
-
740 Y-P for PI3K Signaling Assays
2026-08-20
740 Y-P is a cell-permeable PI 3-kinase activator for controlled interrogation of PI3K/AKT signaling in trafficking, survival, and cancer research. This guide translates pathway biology into practical workflows, assay controls, and troubleshooting decisions while using the ajugol gouty arthritis study as a mechanistic case study.
-
Nitrocefin: Chromogenic β-Lactamase Assay Guide
2026-08-19
Nitrocefin is a chromogenic cephalosporin substrate that converts β-lactamase activity into a yellow-to-red optical signal. Its research value is strongest in controlled colorimetric β-lactamase assays, enzyme characterization, and β-lactamase inhibitor screening, not as a standalone clinical resistance test.
-
(+)-Bicuculline: Practical GABAA Workflow
2026-08-19
(+)-Bicuculline provides a controlled way to inhibit GABAA receptor signaling in neuronal assays and to examine related changes in synaptic NMDA receptor signaling. It is intended for research workflows only, with particular attention to DMSO-based solubilization, low-temperature storage, vehicle controls, and interpretation of potential SK-channel contributions.
-
Bardoxolone methyl: Redox Workflows for Cancer Models
2026-08-18
Bardoxolone methyl, also known as CDDO methyl ester, gives researchers a practical way to probe Nrf2 activation, NF-kB suppression, oxidative stress, and inflammation in disease models. This workflow-focused guide connects redox pathway assays with a recent thioredoxin–RNR study while separating established evidence from exploratory combination strategies.
-
Valemetostat: Dual EZH1/2 Inhibition in ATL
2026-08-18
The reference paper explains why simultaneous inhibition of EZH1 and EZH2 is a rational treatment strategy for adult T-cell leukemia/lymphoma (ATL), where both enzymes can sustain H3K27me3-mediated transcriptional repression. It also reviews the clinical evidence supporting valemetostat, including responses in heavily pretreated relapsed or refractory ATL, while highlighting the need for larger comparative studies.
-
Ceapin-A7 for Selective ER Stress Studies
2026-08-17
Ceapin-A7 enables pathway-level interrogation of ATF6α rather than indiscriminate suppression of the unfolded protein response. This practical guide shows how to deploy it in ER stress assays and how to design an exploratory extension of osteonecrosis research without confusing correlation with validated mechanism.
-
Verbascoside for PKC/NF-κB Signaling Workflows
2026-08-17
Verbascoside provides a practical pharmacological entry point for dissecting PKC/NF-κB-mediated signaling in RANKL-induced osteoclast differentiation and inflammatory cell models. This guide translates its reported activity into dose-finding, pathway-validation, satellite glial cell, and osteoclastogenesis workflows while emphasizing solvent control, temporal design, and orthogonal readouts.